newsroom
Pharmadrug Advances Opthalmology Program with Final Selection of Lead DMT-Analogue to Provide Sustained Control of Elevated Intraocular Pressure for Glaucoma
Results to be leveraged by filing of Provisional Patent detailing a novel approach to treating primary open angle glaucoma
Anfield Energy Announces Upsized C$15 Million Private Placement
Both BRS and Wright Environmental were involved in Uranium One’s previous efforts to permit Velvet-Wood, bringing a wealth of asset-specific experience and knowledge to the effort.
Anfield Energy Announces Transactions to Raise Capital, Retire Debt, and Consolidate Uranium and Vanadium Resources in the USA
Both BRS and Wright Environmental were involved in Uranium One’s previous efforts to permit Velvet-Wood, bringing a wealth of asset-specific experience and knowledge to the effort.
PharmaDrug Advances Oncology Program with Filing of Provisional Patent Following Positive Findings for the Combination of PD-001 and Frontline Chemotherapy in Prostate Cancer Study
Final study results show that oral cepharanthine (PD-001) plus cabazitaxel combination therapy significantly reduced tumor volume and increased tumor growth inhibition